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INTRODUCTION 
 Calculus disease of biliary system is one of the most common 
disorders affecting the gastrointestinal tract constituting a  major  cause 
of morbidity. There has been a marked rise in the incidence of gall 
stone disease in the west during the past century. In the UK, USA and 
Australia, the prevalence rates varies from 15- 25%.  In India, it is 
more common in  North  India than in  South India . Similarly the 
incidence in Eastern India is higher than in the West. 
Incidence of gallstones increases with age. It is more common in 
females than males (M:F = 1:4) . About 50% of patients with gall 
stones are asymptomatic. 1 to 2% of asymptomatic patients will 
develop symptoms requiring cholecystectomy per year, making 
cholecystectomy one of the most common operations performed by 
surgeons. 
The etiopathogenesis of gallstones is multifactorial. It varies 
according to the type of gallstones. Primarily gallstones can be divided 
into two major groups. First is pure gallstones contributing  to 10% of 
gallstones. Second is mixed and combined gallstones which accounts 
for 90% of gallstones.  Mixed gallstones have increased preponderance for 
cholecystitis.  
Infection  seems  to  be   a  major  cause  of    gallstones 
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formation. Moynihan’s aphorism that “gall stone is a tomb stone 
erected in the memory of the organism with in it” is true today. 
Evidence  in  favour  of  infection  includes   isolation of  E.  coli, 
klebsiella,  bacterium typhosum,  streptococcus  from  the   bile within 
the gallbladder.    
           Slow growing actinomyces also have been recovered from the 
bile.   These organisms  reach  the gallbladder  via   blood stream from 
an  infective focus elsewhere in the body and also by lymphatics.     
           Brown pigment gallstones occur as a result of infection. Bacteria 
are  found with in the calcium bilirubinate and protein matrix of brown 
pigment gallstones. 
        Predisposing factors are obesity,dietary factors,liver 
disease,gallblader disease,haemolytic anaemia,gastric surgery  and 
terminal ileal resection. Treatment varies from medical management to 
surgical management. Recently minimally invasive surgery improves 
the patient’s compliance and reduces the morbidity. Sequalae of 
gallstone disease contributes to most of the surgical problems in patients 
with the disease. 
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OBJECTIVES 
   
To study the age, sex incidence and various modalities of clinical 
presentation. 
  Bacteriological analysis of the bile collected from all cases 
subjected to  cholecystectomy in our study so as to identify the 
commonest type of organism associated with gall stones. 
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HISTORY 
 1924 – Findlay introduced the concept that failure of cholesterol 
to remain in solution was the critical factor initiating cholesterol 
gallstone formation. 
 1966  –   Maki  proposed  that  bacterial  infection  plays  a  key  
role  in  the pathogenesis of pigment gallstones. 
 1968  –  Admirand  and  Small  described  the  critical  nature  of  
the  relation between  the  relative  biliary  concentrations  of  
phospholipids,  bile  salts  and cholesterol.  
 1972  –  Tabata  and  Nakayama  found  that  more  than  80%  of  
patients  had evidence of bactibilia (defined as more than 105  colony 
forming units/ml). 
 1982  –  National  Institute  of  Health  International  Workshop  
classified  most pigment gallstones as either black or brown.  
 1984 – In comparing black and brown pigment stones Cetta et al 
found positive bile culture in 25% of patients with black pigment 
stones and in 100%  patients with brown pigment  gallstones. 
 1990 – Fransesco Cetter M. documented for the first time that 
bile infection by E.coli is a  preceding factor in  brown stone formation.  
 1996 – Attila Csendes & Patricio Burdiles found out that no 
bacteria is seen in the bile culture studies of control  groups ,   when 
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compared to bile culture study of patients with gallstone disease. 
 2006 – Crygia Stewart, J. Macleor Grifiss  had postulated that 
biliary bacterial factors determine the pathogenesis of gallstone 
formation. 
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REVIEW OF LITERATURE 
 
Maki   expressed  the classic  theory   of  the pathogenesis  of  
calcium bilirubinate gallstone  formation  in which he emphasized the 
role of infection of  the     stagnated bile  and  the  enzymatic  hydrolysis  
of  bilirubin  glucoronide  into free  bilirubin  and  glucoronic  acid.  
This  free  unconjugated  bilirubin  which  is insoluble in water, then 
combines  with calcium in the bile to produce a calcium bilirubinate 
matrix.  
Stewart  and  co- workers  demonstrated  the  presence  of  
bacteria  in  the interior of most pigment gallstones. 
Kaufman and associates confirmed the role of bacteria in the 
formation of gallstones.   In   their study, bacteria  were  identified  only  
within  the  calcium bilirubinate – protein matrix of brown pigment 
stones. 
In  a review  of  biliary  bacteriology  in  200  consecutive  
patients  with gallstone  disease, Tabata and Nakyama found that more 
than 80% patients had evidence of bactibilia (defined as more than 105  
colony – forming units/ml). 
In comparing black and brown pigment stones, Cetta et al 
found positive bile culture in  25% patients wit h black gallstones and 
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100% patients with brown pigment gallstones. 
Studies  by  Stewart  et  al  and  Smith  et  al  from  the United  
States,  state  that bacteria  were  found  in  the  majority  of  black  and  
brown  pigmented  gallstones concluding  that  the  bacterial  infection  
is  the  primary  factor  in  both  black  and brown pigment gallstone 
pathogenesis. 
Infection has been documented at the time of  gallstone removal 
in more than 90% brown gallstones. Bile infection by E.coli precedes 
rather than follows brown gallstone formation.  
 In 16th century,  vesalius  and  fallopian  described  gallstones  
found  in  the gallbladder of dissected human bodies. 
 In 19th century   – Langenbuch widened the understanding of 
gallstone pathology of gall bladder by performing first 
cholecystectomy.  
 1882  –  Langenbuch  –  first  described  open  cholecystectomy  
as  the  primary treatment for gallstone disease. 
 In 1882  - Karl Langenbach – performed the first successful 
cholecystectomy.  
 In  1867 –   Ioenisus  was  the  first  person  to  extract  gallstone 
s  from  the gallbladder. 
 1891 – Calot described the triangle of cholecystectomy and 
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dissection of this area should show the anatomic structures and 
allow safe dissection. 
 1924 – Schoff – classification of GS.  Classified as – 
Inflammatory gallstones, metabolic (cholesterol) gallstones, 
Mixed gallstones, Pigment gallstones. 
 1978 – Piehler and Crichlow – showed that more than 70% 
patients developing Gallbladder carcinoma have gallstones in their 
gallbladder.   The   risk   of developing carcinoma is about 1% in 
calculous gallbladders  20 years  after  the initial diagnosis of 
gallstones, with more incidence in men.  
 1979 – Smith and Andrens and berg – showed that dangerous 
surgery arises from inadequate or imprecise observation of the 
technical principles of cholecystectomy, insufficient experience, 
inadequate incision and exposure or inadequate assistance.  
Anomalies of the gallbladder and cystic duct should be kept in 
mind. 
 1981 – Schoenfield and Lachin – Treated 144 patients  including 
92 men and  52 women with  symptomatic  gallstones by 
conservative management and about 50% had to undergo 
cholecystectomy as further management. 
 1985 – McSherry and colleagues followed 135 men and wemen 
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with asymptomatic gallstones.  Of these subjects 10% developed 
symptoms and7% required cholecystectomy over a median follow 
up of 46 months. 
 1985 –  Allen et al, showed that direct instillation of MTBE 
(Methyltert- Butyl through a small percutaneous ether)  
cholecystectomy catheter can be used for dissolution of 
gallstones. 
 1985 – Muller et al  –  proposed that MTBE can be used for 
dissolution of gallstones  (cholesterol  stones)  successfully  in  
the  presence  of  an  occluded cystic duct. 
 1986 – Muhe in Boblingen (Germany) performed the first 
laparoscopically assisted cholecystectomy. 
 1989 – Bushenne, Sackman  –  ESWL (extracorporeal shock 
wave lithotripsy) can  be done with ultrasound guidance 
and requires  no percutaneous cholecystectomy. It is restricted 
to definite cases with normal gallbladder on ultrasound, 
opacification of the   gallbladder  on  oral  cholecystography  and 
limited number of gallstones (1- 3)  of  size 0.5 – 3 cm. 
 1990  -  Goldfarb  et  al–   found  that  patients  with  sickle  cell  
disease  and haemolytic  anaemia are at risk of development of 
gallstones (pigmented) and many patients become symptomatic. 
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 1991 – PA grace –     performed the first Lap cholecystectomy.  
 1992 -  IG Marton et al – operated on  162 pateints with 
gallstones. 
 1992  - Ajay K. Kripalani proved that lap cholecystectomy is a 
very safe procedure which   reduces   the   morbidity   and   
mortality   associated   with   surgery   for symptomatic gallstones. 
 1992   –   Gillams   et   al,   Hurby   et   al,  showed that  the   
success   rate   of   percutaneous cholecystolithotomy  is  88%.      
  Procedure  related  complications  occur  in  15% and  includes  
subhepatic  bile  collections,  cholangitis,  gallbladder 
perforation,  pericholecystitis and wound infection. Most cases 
are done on an elective basis under local, intravenous or general 
anaesthesia. 
 1992 – Analysis of the natural history of  gallstones by Gracie 
and Ransohoff. He  followed  123  patie nts (110  men,  13  
women)  who  had  been found   to have  gallstones through 
routine screening  for 15 years . At 5, 10 and 15 years of follow  
up,  10%,  15%  and  18%  respectively had  become  
symptomatic and  none  of  them developed complication before 
the onset of typical symptoms. 
 1993 – IMC Macintyre and RG Wilson  showed that   lap 
11 
 
cholecystectomy  reduced the hospital stay to < 2 days and 
return to work with in 2 weeks. 
 1993 – Wada and Imamura found in 1850 patients with 
gallstones that  one third of patients were   symptomatic and 20% 
of asymptomatic patients become symptomatic over a median 
follow up of  13 years. Patients older than 70 years were more 
likely to become symptomatic. 
 1995  –  Shyamal  Kumar  Gosh  et  al   showed a  female  
preponderance  for  GS disease. 
 1996 - Carter Dc, Russel, Bismuth H   –  in their book on  
hepatobiliary and pancreatic surgery mentioned about congenital 
anomalies of GB. 
 1996 – J.R. Barton et al - complications after lap 
cholecystectomy like bile leak can be managed endoscopically by 
stenting or sphincterotomy.  
 1996 –  Majeed and Assalia  –  have done minilaparotomy 
cholecystectomies for 23 patients with  gallstones t h r o u g h  
smaller abdominal incisions. 
 1998 – GPH, GUI, CVN Chruvu et al, operated  on 92 patients 
with symptomatic gallstones and cholecystectomy  improved the 
symptoms suggesting that surgery remains the gold standard for 
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symptomatic treatment for gallstones. 
 2000 – UL Wills et al showed that laparoscopy is useful in the 
management of minor bile  leak after laparoscopic 
cholecystectomy.  
 2002 – Michael Rosen et al - Laparoscopic cholecystectomy 
were performed in 1347 patients. Out of this 71 patients 
required conversion to open surgery. Obese  patients  with  
cholelithiasis  have an  increased  chance  of  conversion    to  
open  surgery.  Patients  with  multiple  co- morbid disease s   
have  more   chances  of  failure of laparoscopic cholecystectomy 
 2002 –Nakeeb and co- workers established that  genetic factors
 were responsible for at least 30% symptomatic gallstone 
disease. 
 2002  –  Schiffman  and  associates studied  that  there  was a  
decrease  in  gallstone formation in  obese persons who were on a 
low calorie diet for long periods. They also  stated  that  previous  
gastric  bypass  surgery  increases  the  incidence  of gallstone 
formation. 
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PHYSIOLOGY OF BILE: 
 Bile is made up of the bile salts, bile pigments and other substances 
dissolved in an alkaline electrolyte solution. Bile is secreted in two stages. 
(1) The first phase of secretion is by the principal hepatocytes. This 
secretion contains large amounts of bile acids, cholesterol and other 
organic constituents. It is secreted into minute bile canaliculi that lie 
between the hepatic cells. The canaliculi empty into terminal bile 
ducts and then into progressively larger ducts, finally reaching hepatic 
duct and common bile duct. 
(2) The second phase of secretion is a watery solution of sodium and 
bicarbonate ions secreted by secretory epithelial cells that lines the 
ductules and ducts. 
        The normal bile secretion is between 600 – 1000ml/day. The second 
phase of secretion sometimes increases the total quatity of bile by as much 
as an additional 100%. 
BILE ACIDS: 
 Bile acids are the major organic constituents of bile accounting for 
approximately 50% of the solid components. They are related structurally to 
cholesterol from which they are synthesized by the liver. Cholesterol in the 
liver is converted into cholic acid and chenodeoxycholic acid through 
several intermediate steps of which 7 alpha hydroxylase is the rate limiting 
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enzyme. These acids called primary bile acids. In the colon, bacteria convert 
cholic acid to deoxycholic acid and chenodeoxycholic acid to litho cholic 
acid .  These are called secondary bile acids. 
 Bile salts are sodium and potassium salts of bile acids conjugated to 
glycine and taurine ,a derivative of cysteine. Conjugation occurs in the liver 
producing glycocholic acid and taurocholic acid.  
ACTIONS OF BILE SALTS: 
(1) They reduce the surface tension and are responsible for the 
emulsification of fat preparatory to its digestion and absorption in the 
small intestine. 
(2) Bile salts tend to form cylindrical discs called micelles with the 
hydrophilic surface facing out and the hydrophobic surface facing in. 
Above a certain concentration called the critical micelle 
concentration,  all bile salts added to a solution form micelles. 
(3) The micelle plays a important role in keeping the lipids in solution 
and transporting them to the brush borders of intestinal epithelial cells 
where they are absorbed. 
(4) 90 – 95 % bile salts absorbed from the termimal ileum, remaining 5 – 
10 % of the bile salts enter the colon and are converted to salts of 
deoxycholic acid and lithocholic acid. Lithocholate is relatively 
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insoluble and is mostly excreted in stools, only  1% is absorbed 
,however deoxycholate is absorbed. 
(5) The absorbed bile salts are transported back to the liver in the portal 
vein and re excreted in the bile (entero hepatic circulation). Those lost 
in the stools are replaced by synthesis in the liver. The normal rate of 
bile acid synthesis is 0.2 to 0.4 gms/day. 
BILE PIGMENTS: 
           Bilirubin and biliverdin are the two major bile pigments present in the 
body. During the breakdown of haemoglobin in the reticuloendothelial 
system, bilirubin is formed and transported to the liver. In the hepatocytes 
bilirubin is conjugated by the enzyme UDP glucuronyl transferase and 
excreted into the bile which is responsible for the characteristic golden 
yellow colour of the bile. 
 In the terminal ileum and the colon, the bilirubin is deconjugated by 
the specific bacterial enzymes (beta glucuronidase) and the pigment is 
reduced to urobilinogen. Most of the urobilinogen is excreted in the faeces 
as urobilin whereas a small portion of the urobilinogen is reabsorbed and 
reexcreted through the liver to constitute the enterohepatic urobilinogen 
cycle. 
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ENTEROHEPATIC CIRCULATION: 
 About 90-95% of bile salts are absorbed back from the small intestine. 
They then enter the portal blood and pass back to liver and are resecreted 
into the bile.On an average, these salts are circulated about18 times before 
being excreted. The remaining 5-10% of bile salts enters the colon and are 
converted to salts of deoxycholic acid and lithocholic acid. A small fraction 
of the bile salts about 500mg/day escapes absorption and is therefore 
eliminated in the faeces 
Constituents Liver bile 
pH – 8 to 8.6 
Gall bladder bile 
pH – 7 to 7.6 
Water 97.5 g/dl 92 g/dl 
Bile salts 1.1g/dl 6 g/dl 
Bilirubin 0.04 g/dl 0.3 g/dl 
Cholesterol 0.1 g/dl 0.3 -0.9 g/dl 
Fatty acids 0.12 g/dl 0.3 – 1.2 g/dl 
Lecithin 0.04 g/dl 0.3 g/dl 
Sodium ion 145 mEq/L 130 mEq/L 
Potassium ion 5 mEq/L 12 mEq/L 
Calcium ion 5 mEq/L 23 mEq/L 
Bicarbonate ion 28 mEq/L 10 mEq/L 
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Characteristics Black Brown 
Appearance Shiny Dark brown 
Crushing resist manual crushing Easily crushable 
Site Gall bladder Biliary tract 
Association Haemolysis and cirrhosis No such association 
Calcium bilirubinate 40% 60% 
Calcium palmitate Trace 15% 
Calcium carbonate 6% Trace 
Cholesterol 2% 15% 
Bile Sterile Infected 
Appearance Shiny Dark brown 
Crushing resist manual crushing Easily crushable 
Site Gall bladder Biliary tract 
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FUNCTIONS OF BILE: 
(1) Bile salts helps in digestion and absorption of fats and fat soluble 
vitamins. 
(2) Neutralisation of acids. 
(3) Facilitates excretion of drugs, toxins, bile pigments and various 
inorganic substances 
(4) Large quantities of cholesterol present in the bile are solubilised in 
micelles allowing cholesterol to be transported without precipitation 
in bile. 
  EFFECTS OF CHOLECYSTECTOMY: 
(1) Bile from the liver empties slowly but continuously into the intestine, 
allowing sufficient digestion of fats to maintain good nutrition. 
(2)  Bile ducts become dilated to accommodate some of the bile which is 
continuously secreted by the liver. Therefore if the tone of sphincter 
of oddi is high, it causes gradual rise of pressure  in the biliary 
passage. When this pressure exceeds secretory pressure of the liver 
cells, it interferes with bile secretion. If the tone is low, it causes 
dribbling of bile into the intestine when it is not needed and results in 
wastage of bile. 
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BILIARY SLUDGE: 
           Biliary sludge is composed of mucin, calcium, mono conjugated 
bilirubin and cholesterol and is now thought to be the direct precursor of gall 
stones. 
GALLSTONES 
CLASSIFICATION : 
Gallstones are classified into two types - 
1) Pure gallstones 
Cholesterol gallstones 70% Pigment gallstones 30% Calcium carbonate 
gallstones 
2) Mixed and combined stones 
10% gallstones are  cholesterol  stones.They are usually  solitary  
with smooth surface,   oval or round in shape, pale yellow in colour.   
They are thought to be formed in  aseptic static bile and commonly  
found in Hartman’s pouch. On section,  they  show  radiating   lines  
crossing  the  circular  strata.  In  combined gallstone , the stone starts 
as pure cholesterol stone but ultimately receives mixed covering of 
pigment and cholesterol. 
Pigment stones :  May  be  pure  or  contain  Calcium  
bilirubinate.  They constitute  about 80% of all gallstones.  They are 
dark or black brown in colour , found  exclusively  in  the  gallbladder  
20 
 
associated  with  excessive  haemolysis  like hereditary spherocytosis, 
sickle cell disease, thalassemia etc. Excessive breakdown of Hb results 
in an increase in bilirubin which are excreted in the bile and forms 
pigment stones in the gallbladder. Stones usually appear as small soft 
fat like masses. 
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Cholesterol gallstones 
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Calcium  bilirubinate  stones  are  brown  to  orange  in  colour  and  
soft  in consistency. These stones are more often seen in the bile ducts. 
These stones are often caused by infect ion (E.Coli and parasites).8 
Calcium carbonate stones –  rarest type of stones.  They are 
grayish white in colour  with smooth surface or articulated surface. 
Increased alkalinity of the bile favours this stone formation. 3 
2) Mixed or combined stones : 
Mixed  stones  have  varying  proportion  of  all  three  of  the  
stone  forming constituents  of the bile eg. cholesterol, bile pigment and 
calcium. They constitute about 10% of gallstones. 
Combined stones are those in which the central core or external 
layers are pure and the reminder of the stone is a mixture of the 
constituents. Combined stones may be solitary but mixed  gallstones 
are invariably multiple with faceted surface. Stones may vary in size 
from a few cm in diameter. Colour of the stone depends on the 
constituents of stones.7 
Pale yellow - Cholesterol 
Black - Calcium bilirubinate 
Grayish white - Calcium carbonate. 
On section the  laminated central nucleus may contain epithelial 
debris and bacteria. This suggests an inflammatory origin of stones. 
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Mixed stones are frequently associated with cholecystitis.   In about ½ 
the cases bacteria can be cultured from these  gall  bladder  bile.  C 
hemical   inflammatory  changes  prepare  the  soil  for 
bacterial invasion. 
 
 
PIGMENT GALL STONE 
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EPIDEMIOLOGY OF GALLSTONES : 
 It provides information about the prevalence and incidence of the 
disease. 
a. True incidence : 5 year incidence in women aged 30, 40 , 50, 
and 60 are (4%), (3.6%), (3%)  and (3.7%) years and the same 
incidence rate in men were 0.3%, 2.9%, 2.5% and 3.3% at the 
same age . This shows that the incidence is more in women. 
b. Prevalence and incidence : Gallstones are two times more 
common in women than  in  men.   The  incidence  of  gallstones  
in  general  population  is  10%. Prevalence of gallstones in 
women between the ages 20 to 55 varies from 5% - 20% and 
after 50 years 25% - 30%.  The prevalence in men is 
approximately half of that of women. 1 
c. Ethnic  predisposition  : Certain  genetic  factors  play  a  
key  role  in  the pathogenesis  of  gallstone  disease.  Several  
genes  that  are  associated  with gallstone  formation and 
resistance are identified in mice. The importance of these  genes  
in  human  gallstone  formation  has  not  been  established.  
Pima Indians   in  southern  Arizona  are  an   example  of  an  
extremely  high  risk population  in  which  70%  of  women  less  
than  25  years  are affected by the disease.39 
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Populations at the lowest risk are sub Saharan Africans and 
Asians. 
d. Risk   factors   :   Gallstone   disease   is   multifactorial   in   
origin   and   occurs sporadically. Specific risk factors 
predisposing to gallstones have been identified. 
1) Age and gender: 
Gallstone  disease  increase s  with  age  as  cholesterol  secretion  
into  bile increases with age and bile acid formation decrease with age.  
Hence bile becomes more lithogenic with increasing age.1 
Most studies report that the incidence and prevalence of 
gallstones is three to four fold  higher  in women  than in men. But 
after age of 50 years, the incidence may become equal in male and 
females. This may be due to an increase in oestrogen in young women 
leading to an increased secretion of cholesterol into bile.27 
2) Pathophysiology of gallstone formation with aging : 
Changes in bile  composition with aging accounts for an 
increase in the risk of cholesterol  gallstone  formation.  Biliary  
cholesterol  saturation  index  (CSI) rises with  age  in  both  men  and  
women.  This may  be  due  to  an increase in hepatic cholesterol 
secretion, but bile salt and phospholipids secretion remains stable. An 
inverse relation  was seen between  the  age  and  hepatic  bile  salt  
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synthesis  and activity of enzyme 7 alpha hydroxylase (rate limiting 
enzyme for bile salt synthesis).3 
Factors that change with  age, like change in contraction of 
gallbladder, ability to  concentrate bile are also incriminated in 
gallstone formation including pigment or mixed stones.2 
3) Obesity, weight loss and total parenteral nutrition : 
Obesity is a well known risk factor for cholelithiasis . Gallstone 
formation is directly related to body mass index (BMI = kg /m2 ).  
Highest BMI (45 kg/m2 ) has got  seven  fold  increased  risk  of  
gallstone  formation  as  compare  to  non  obese persons. This obesity 
related  increase  in  gallstone  formation  is  more  in  women than in 
men. 38  
Rapid   weight   loss   is a recognized   risk   factor   for   gallstone   
formation. Gallstone develop in approximately 25% of obese persons 
on restricted diet intake and in upto 50% of  patients who have 
undergone gastric by pass surgery. Gallbladder sludge or gallstone 
formation occurs  within 6 months of surgery.  Around 40% o f  these 
patients experience the symptoms of gallstones.20,40 
The physiological alterations that lead to gallstone formation as a 
result of rapid weight loss are multiple. 
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i. Hepatic cholesterol secretion increase during caloric restriction. 
ii. Increased secretion of mucin which is a  potent stimulator of 
cholesterol crystal formation. 
iii. Decreased gall bladder motility leading to biliary sludge 
formation. Gallstone formation can be prevented  by 
administration of ursodeoxycholicacid  in  these  patients.  It  is  
also  found  that  there  is  a  decrease  in gallstone formation in 
obese persons who are taking low caloric diet.40 
 TPN  is   associated   with   the   development   of   acalculous   
cholecystitis, cholelithiasis and cholecystitis. In 45% adults and 43% 
children, gallstones develop after 3- 4 months of TPN. Gallbladder 
sludge is seen in TPN as early as after 3 weeks due  to  hypomotility  
with  bile  stasis  and  due  to  failure  of  sphincter  of  oddi  to relax. 40 
4) Pathophysiology of gallstone formation in obese persons : 
In obese persons hepatic cholesterol synthesis is increased and 
cholesterol saturation  index (CSI) is more. Gallbladder bile is 
supersaturated with cholesterol. Secretion of bile salts and 
phospholipids is either normal or increased. Gallbladder contractility  
may  be  decreased  in  the  obese  persons.  So  gallbladder  stasis  with 
supersaturated bile lead to ga llstone formation. 38 
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5) Pregnancy and parity : 
Due to an increase in oestrogen level bile becomes more 
lithogenic due to an increase in  cholesterol  secretion and 
supersaturation of bile .  Gallbladder volume  will be doubled and stasis 
develops with formation of biliary sludge.  Higher progesterone levels 
also impair gallbladder motility. 21 
Both  biliary  sludge  and  stones  are  silent  in  nature  but  they 
may  become symptomatic. After delivery in 60-70% pregnant woman, 
biliary sludge disappears and gallstones disappear in 20-30%. 
6) Drugs : 
 Drugs which increase the gallstone formation are oestrogens, oral 
contraceptives, clofibrate, octreotide, ceftriaxone (third generation 
cephalosporin). 
Oestrogen : The observations that gallstones are seen more in 
reproductive age group led to initial hypothesis that oestrogen may 
promote gallstone formation. 
 Exogenous   estrogen   increases   biliary   cholesterol   secretion   
by   40%   causing cholesterol  supersaturation  of  bile .  Estrogen 
therapy also decrease plasma LDL and increase plasma HDL.   There 
is an increased LDL receptor expression by liver in estrogen therapy 
which results in an increased uptake of LDL by liver and increased 
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secretion of cholesterol into bile.1,21 
Clofibrate  : Induces  cholesterol  supersaturation  in  bile  and  
decreases  bile  acid concentrations   by  reducing  the  activity  of  
enzyme  7 alpha  hydroxylase,  the  rate limiting  enzyme  in  the  
pathway  of  bile  acid  synthesis.   HMG Co-A reductase inhibitors   
reduce   the   biliary   cholesterol   saturation   index   but   their   role   in 
prevention of   or therapy of gallstone disease has not been clearly 
established.21 
Octreotide, a  somatostatin   analogue   increases   the   gallstone   
formation. Decreased   gallbladder  motolity  and  bile  stasis  are  
associated  with  octreotide treatment and leads to gallstone formation. 
Ceftriaxone  is  generally  excreted  in  the  urine  but  upto  
40%  is secreted unmetabolised in the bile and reaches 100-200 times 
the concentration in serum. Once it exceeds  the saturation level, it 
combines with calcium and forms insoluble salt.  In 43% children who 
receive ceftriaxone in high doses (20 – 100 mg/kg/day), biliary 
symptoms are reported. 
7) Diet : 
Hypertriglyceridemia is associated with an increased  incidence 
of gallstone formation.  High serum cholesterol does not seem to be a 
risk factor for gallstone formation.  HDL levels are inversely 
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correlated with the development of gallstones. 
 Hence  obese  persons  with  hypertriglyceridaemia  with  low  
HDL  levels  are  at greatest  risk  for  development  of  gallstones.  
Ingestion  of  refined  sugars  and low  physical activity are positively 
associated with the presence of gallstones in some studies.  No  
association  between   alcohol,   tobacco   or   caffeine   ingestion   and 
gallstone formation has been found.2,38  
8) Systemic diseases : 
Gallstone formation is common in diabetic persons and its 
complications are also more. Insulin resistant diabetes mellitus 
is associated with hyper triglyceridemia,  obesity, hypomotality  of  
gallbladder  leading  to  biliary sludge formation which inturn may lead 
to gallstone formation. 38  
 The prevalence of gallstones in persons who had spinal cord 
injury is about 31% and biliary complications occur in 2.2%.  The 
mechanism responsible for the association  between  spinal  cord  
injuries  and  gallstone  formation  is  not  known. Gallbladder relaxation 
is  impaired  in  these  patients.   Hence  biliary  stasis  is  likely to be the 
cause of gallstone formation. 38  
9) Cirrhosis of liver : 
Gallstone  formation  i   s  2- 3  times  greater  in  cirrhotic  patients  
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than  a  non cirrhotic population at all ages. In advanced cirrhosis, there 
is a marked reduction in the bile salt secretion. It is stated that decrease 
in bile salt is matched by diminished biliary lecithin and cholesterol 
and bile is not lithogenic. Gallstone in cirrhosis and other chronic liver 
disease is usually due to chronic haemolysis and majority of the stones 
are pigment type. Jaundice in cirrhosis is more likely to be due to 
hepatic decompensation than a stone in the CBD.26 
10) Ileal disease or resection : 
In crohn’s disease,  extensive involvement of ileum and major 
resection of  ileum  lead  to  mal absorption  of  bile  salts. This  inturn  
leads  to  increased cholesterol   and   supersaturated   bile.   Therefore   
gallstone   formation   is   more. Gallstones are usually cholesterol 
type.40,26 
11) Gastric surgery : 
 Gastric bypass surgery  for peptic ulcers  and for gross obesity
 is complicated with an increase in prevalence of gallstone 
formation.  Truncal vagotomy will adversely affect gallbladder 
emptying or bile lipid composition. 40  
12) Haemolytic anaemia : 
Patients with haemolytic anaemia and hereditary spherocytosis 
are associated with an increased incidence of pigment gallstone 
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formation due to haemolysis.1 
Prevalence rate : 
 In hereditary spherocytosis is about 43.66% In sickle cell 
anaemia 37%. Thalassaemia 10% Saudiarabs with sickle cell anaemia 
have milder haemolysis due to increased alkali resistant Hb and have 
got low rate of gallstone formation.  
13) Other conditions : 
Children   with   cystic   fibrosis   have  an  increased   incidence   
of   gallstones. Association with  peptic ulcer and hyperparathyroidism  
–  a firm evidence is not available. 
PATHOGENESIS OF GALLSTONE DISEASE 
       Pathogenesis of gallstone is multifactorial. There a re significant 
difference in the etiology of cholesterol and pigment gallstones. The 
understanding of this factor is important to prevent  the  disease and 
for treatment modalities. Gallstones are concretions and aggregations 
that are formed as a result of imbalance between bile acids and 
cholesterol in the ratio 1:10. 
Gall stone disease is due to 
1. Metabolic causes  
2. Infections and infestation 
3. Stasis of bile 
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CHOLESTEROL GALLSTONES : 
 The formation of cholesterol stones involves seven processes. 
(1) Super saturation of bile with cholesterol. 
(2) Incomplete transfer of cholesterol from the biliary vesicles to the bile salt 
micelles. 
(3) Formation of abnormal high cholesterol containing biliary vesicles. 
(4) Aggregation and fusion of unstable vesicle. 
(5) Cholesterol crystallisation, nucleating and anti nucleating factors. 
(6) Biliary sludge formation. 
(7)  Stone growth. 
SUPERSATURATION WITH CHOLESTEROL: 
 Cholesterol is secreted by the hepatocytes into the hepatic bile as 
cholesterol phospholipid vesicles. The cholesterol and phospholipid 
molecules  form a central core surrounded by bile salt molecules. This 
mechanism maintains cholesterol in solution. Methods used to express the 
solubility of cholesterol in bile are percentage saturation, the lithogenic 
index and the ratio of the concentration of bile salts and phospholipid over 
the concentration of cholesterol. The lithogenic index is the ratio of the 
actual amount of cholesterol that can be dissolved in the bile sample using 
the triangular co ordinate plots. A lithogenic index of unity or greater 
indicates that the bile is supersaturated with respect to cholesterol. The 
34 
 
normal ratio concentration of bile salts + concentration of phospholipids/ 
concentration of cholesterol= 10 : 1. 
      Source of the supersaturated bile is the liver from increased synthesis 
of cholesterol or a decreased synthesis / secretion of bile salts and 
phospholipids. In obese patients there is an increased activity of the enzyme 
hydroxyl methyl glutaryl Co A(HMG Co A) reductase resulting from the 
chronically elevated levels of insulin found in over weight individuals. Most 
non obese patients with cholesterol stones have a reduced absorption as the 
cause of the diminished bile salt pool in these patients. The most likely 
explanation of the super saturated bile is an exaggeration of the normal feed 
back mechanism between the bile salt return and the hepatic synthesis of bile 
acids together with an increased entero hepatic cycling possibly consequent 
to an abnormal excessive gall bladder contractility. Other factors are 
persistence of biliary vesicles and kinetic factor. 
BILIARY VESICLES: 
 Under normal conditions, the cholesterol phospholipids vesicles are 
relatively stable  and disappear as micelles form and take up their cholesterol 
and phospholipids constituents. In the pathological state, the phase change to 
micelles is incomplete and as more phospholipids than cholesterol is 
extracted into micellar aggregates with bile salts, biliary vesicles with an 
abnormally high cholesterol phospholipid ratio are produced. These 
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abnormal vesicles are unstable and are the source of cholesterol mono 
hydrate crystals in the bile. The crystallisation is preceded by aggregation 
and fusion of high cholesterol containing vesicles.  
KINETIC BALANCE BETWEEN NUCLEATING AND ANTI 
NUCLEATING FACTORS: 
 Bile contains substances which either  inhibit (alipoprotein A1) or 
promote(mucin) the growth of cholesterol crystals. An anionic polypeptide 
fragment of high density lipoprotein oiccurs in bile and together with 
immunoglobulin A constitutes the lipoprotein complex of bile. Absolute or 
relative decrease in the amount of anionic polypeptide fragment favours 
nucleation and growth of cholesterol monohydrate and pigment crystals. 
Mucin is a major component of biliary sludge and stone formation appears 
to start in the mucous gel. Recently a protein with marked nucleation 
promotion activity for cholesterol crystals that binds to concavalin A has 
been isolated from the bile of patients with and without gall stones. Its 
activity was found to be increased in patients harbouring gall stones.  
OTHER FACTORS: 
 The role of calcium is indicated by the presence of calcium salts in the 
majoritiy of stones, with an increase in the total and free ionised calcium 
concerntration in the gall bladder bile. Gall bladder may alter the 
physicochemical composition of bile, favouring nucleation and crstal growth 
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by abnormal absorption/ secretion, defective surface pH, stasis resulting 
from impaired gall bladder emptying and stratification of bile or by 
providing essential nucleating factors including  mucin, desquamated cells , 
bacteria and refluxed intestinal contents. 
GALLBLADDER FACTORS : 
Gallbladder contributes in gallstone formation by a complex 
interaction of muscular and mucosal events. 
a) Stasis : 
Many  patients  with  gallstones  have  gallbladders  that  empty  
more slowly, incompletely.  This muscle abnormality precedes gallstone 
formation and persists after  the  gallstone  have  been  removed  by  
dissolution  therapy.This  stasis  is  a feature of both cholesterol and 
pigment stones. Other factors are sequestration of bile acids within the 
gallbladder reducing the amount of bile salts available for cholesterol 
solubilisation, alterations  in  the  secretory  or  absorptive  function  of 
gallbladder leading to biliary stasis.23 
b) Phospholipids in bile : 
Studies indicate that gallstone formation is accompanied by an 
increase in arachidonic  acid  containing  phospholipids.  Increased  
hydrolysis  of  arachidonyl lecithin provides the substrate for formation 
of prostanoids in the gallbladder wall. This activation of the  prostanoid  
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synthetic  cascade  is   accompanied by reduced gallbladder   motility   
and   increase   in   mucin   production   by   the   gallbladder mucosa.12 
c) Bile mucus glycoprotiens : 
The excessive production of glycoprotiens by gallbladder mucosa 
precedes stone  formation. Mucin gel interferes with gallbladder 
contractility and emptying  and  acts  as  a   nucleating  matrix  for  
cholesterol  crystals  to  form      cholesterol phospholipids vesicles. 
d) Calcium : 
Role of calcium is indicated by the presence of calcium salts in 
majority of gallstones.  Preliminary  results  suggest  that  gallbladder  
bile  from  patients  with cholesterol gallstones contain high levels of 
calcium.  Exact mechanism by which biliary calcium increases the  
formation gallstones remains unknown but possible explanation includ 
es enhanced absorption  of  H2O and solutes by the gallbladder and 
increased gallbladder secretion of  calcium, or decreased absorption of  
calcium. Crystalline structures of  calcium carbonate and cholesterol 
monohydrate crystals provide the frame work for gallstone formation. 
In addition to the structural role , data suggests  that  calcium  promotes  
fusion  of the  vesicles  and    cholesterol crystal growth.  
I N F E C T I O N S   A N D    I N F E S T A T I O N S 
 B  a c t e r i a  l i k e   E . C o l i  , K l e b s i e l l a , S a l m o n e l l a , P a r a s i t e s   l i k e    C l o n a r c h i s   s i n e n s i 
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s  a n d  A s c a r i s   l u m b r i c o i d e s  
PIGMENT STONES: 
 These stones contain less than 30% cholesterol. They are two types 
black and brown.  
BLACK PIGMENT STONES: 
           Black stones are largely composed of an insoluble bilirubin pigment 
polymer mixed with calcium phosphate and calcium bicarbonate. Overall 20 
to 30% of stones are black. Black stones accompany hemolysis, usually 
hereditary spherocytosis or sickle cell disease. Cirrhotic patients have an 
incidence of black stones. In cirrhotic patients, an elevated concerntration of 
mono conjugated bilirubin and a lower bile salt concentration than normal 
causes high prevalence of black stones. Black pigment stones have a bile 
which is supersaturated with calcium bilirubinate and significant increase in 
the gall bladder concentration of unconjugated bilirubin and calcium were 
documented. Calcium is a universal component of black pigment stones and 
both free and total ionised calcium is increased. Patients with bile acid 
malabsorption have low biliary cholesterol in addition to a reduced bile salt 
pool. There is increasing evidence for the important role of some mucins 
especially( MUC 3 and MUC 5B) in the development of pigment stones. 
The peribiliary glands are the source of the mucins. Increased mRNA 
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expression of MUC 3 and MUC 5 in the cells of peribiliary glands of stone 
harbouring intra hepatic ducts is seen. 
BROWN PIGMENT STONES: 
 It is caused by infection by gram negative bacteria such as E coli, 
klebsiella and bacteriodes fragilis which elaborate and release beta 
glucuronidase in the bile. In many eastern countries, where infestation with 
Ascaris  lumbricoides is endemic, the eggs of this parasite have been 
repeatedly identified in the nucleus of brown pigment stones. The bacterial 
beta glucuronidase is implicated in the hydrolysis of conjugated bilirubin 
with consequent precipitation of insoluble calcium bilirubinate. Brown 
pigment stones contain calcium bilirubinate, calcium palmitate and calcium 
stearate as well as cholesterol. They form in the bile duct and are related to 
bile stasis and infected bile. It is associated with the presence of foreign 
bodies within the bile ducts such as endoprosthesis(stents) or parasites such 
as Clonorchis sinensis and Ascaris  lumbricoides.   
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Composition of different types of gallstones : 
Chemical Pathogenesis Morphology 
Cholesterol stones 
(10%) 
Supersaturation of bile 
Bile stasis 
Infection (rare) 
Large, smooth 
solitary, yellowish in 
colour upto 
4cm in diameter 
radiolucent. 
Pigment stones (80%) 
 Calcium bilirubinate 
 Cholesterol with 
calcium bilirubinate 
Haemolytic disorders 
(H.anaemia, infection, 
H.spherocytosis, 
Sickle cell anameia) 
Multiple, jet black 
shiny, jackstones 0.5 – 
1cm in diameter 
uniform in size and 
friable. 
Mixed stones (5- 
10%) 
Cholesterol is the 
major constituents. 
Mixture of 
cholesterol, bile 
pigment, calcium salts  
Combination of bile 
constituents 
Bile stasis 
Infection 
Multip le, hard faceted 
or irregular mulberry 
shape color – yellow 
to green, black 10% 
radio -opaque. 
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Calcium carbonate 
stones 
(rare) 
Excess calcium 
excretion in bile 
Faceted, grayish in 
colour, radio -opaque. 
 
CLINICAL MANIFESTATIONS 
Majority  of  patients  with  gallstone  are  asymptomatic.  Some   
have atypical or  nonspecific symptoms. Others will manifest with 
clinically significant symptoms of gallstones. 
Gallstone disease symptoms may be acute, chronic or totally 
absent. The differentiation between silent and symptomatic gallstones 
is important since this affects the management in individual case. 
1) Asymptomatic or silent stones : 
About 85-90% of patients  with  gallstones  remain  
asymptomatic.  The probability of a patient with silent gallstones 
developing biliary related pain is 1-2% per year and risk of developing 
complication like perforation and emphysema is even less  (0.1% per 
years).   The yearly risk of biliary pain decrease with time and 
gallstones in females are more likely to become symptomatic . In 90% 
of cases of carcinoma - gallbladder, gallstones are present. 
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2) Flatulant dyspepsia : 
 This is the most common symptom and is described as feeling 
of fullness after  food   associated  with  belching  and  heart  burn.  
This  is  more  commonly qualitative dyspepsia – for  fatty food. This 
symptom occurs irregularly and lacks the periodicity of peptic ulcer. 
 Other conditions like hiatus hernia, peptic ulcer and chronic 
pancreatitis should be ruled out before the diagnosis of cholelithiasis is 
made.  
3) Rt. hypochondrial pain :  
 In some, it may be discomfort and in some it may be excruciating 
pain. Pain radiates  to the  interscapular  region  or  right  intra 
scapular area. Patient may complain of aching pain over the tip of the 
right shoulder. Due to distension of the gallbladder diffuse epigastric 
pain may be complained off.   Localized pain may be due to 
inflammation of parietal peritoneum. 
4) Biliary colic : 
It is a misnomer, as the biliary symptoms are usually gradual in 
onset and pain is localized to the rig ht upper quadrant (right 
hypochondrium) or epigastrium and is not a colicky pain, colic occurs 
when a stone is impacted in the cystic duct or at the Hartmann  pouch.  
Episodes  of  biliary  pain are  typically  seen  after  meals  and  often 
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associated  with  nausea  and  vomiting.  Pain  lasts  for  minute  to  
hours  and  may radiate  to  the  back  or  tip  of  the  right  scapula,  pain  
resolves  spontaneously  or diminishes with analgesics.26 
5) Jaundice : 
 Cholestatic  jaundice  due  to  complete  obstruction  of   common  
bile  duct (CBD) and mild or incomplete obstruction. 
6) Fever : 
Occurs in 1/3 of patients and may be present during an attack of 
colic. Fever may be seen without cholangitis, and may be associated 
with rigors. 
7) charcot’s triad       
                  Pain, fever and jaundice.  Due to cholangitis 
 
PHYSICAL SIGNS : 
1. Enlarged gallbladder may be palpable if there is 
mucocele or emphysema.  Enlarged gallbladder is seen  
cholelithiasis  when  there  is double  impaction of stones i.e.one 
in cystic duct and other in CBD. Enlarged gallbladder  is felt  
as  a globular  swelling  projecting  downwards just lateral to the 
right rectus muscle below the tip of ninth rib. It moves with 
respiration and side wards. 
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2. Tenderness and rigidity in right hypochondrium. 
3. Murphy’s sign (Moynihan’s method) – patient is asked to take 
deep breath in and  pressure  i s  exerted  with  the  fingers  to  
palpate  the  fundus  of  the gallbladder.  The  gallbladder  descends  
and  hits  the  finger,  the  patient winces with pain with a catch in 
the breath.  This examination can be done in the sitting posture.  
This is present in acute cholecystitis. 
4. Baos  sign  :  Hyperaesthesia  between  the 9   th   to  11th   rib 
posteriorly on the right side. It suggests acute cholecystitis. 
 
COMPLICATIONS  OF GALL STONE DISEASE: 
IN THE GALL BLADDER: 
(1) Acute cholecystitis 
             It is most commonly obstructive in nature, from the impaction of a 
stone in cystic duct, hartmann’s pouch. Initial inflammation is chemically 
induced and is followed by bacterial infection. 
                           The clinical picture varies with the severity of the inflammatory 
process. In mild cases, the patient complains of right upper quadrant pain 
and tenderness. Pyrexia, severe pain and tenderness in the right 
hypochondrium suggest more severe degrees of gall bladder inflammation. 
Murphy’s sign (inspiratory arrest due to pain on inspiration during gentle 
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palpation of the right sub costal region) is usually present. Nausea, vomiting, 
ileus, mild abdominal distension and toxicity are encountered in severe form 
of the disease. Jaundice is present in 20-25% of patients with acute 
cholecystitis. Finally the natural course of the disease follows any one of the 
following patterns namely 
¾ Resolution – complete 
¾ Persistence of infection – empyema of gall bladder 
¾ Resolution of inflammation within the gall bladder with persistence of 
cystic duct obstruction – mucocele 
¾ Gangrene – perforation – peritonitis 
¾ Fistula formation 
This course of the disease is altered by medical intervention. 
(2) Empyema (suppurative cholecystitis) 
2-3% incidence 
            It presents as a tender mass in the right hypochondrium and usually 
affects elderly patients in whom systemic signs, including pyrexia and 
leukocytosis are more prominant. Cultures of the contents are positive in 
80%. It doubles the mortality figures of cholecystectomy. 
(3) Gangrene 
        Patchy gangrene of the fundus of the gall bladder is present in 5-7% 
patients. It is more commonly present in elderly patients, diabetics, and in 
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patients with empyema of the gall bladder, acute acalculous cholecystitis and 
especially emphysematous cholecystitis. It may lead to localized free 
perforation of the gall bladder. 
(4) Perforation 
       Perforation may be localized with the development of a 
pericholecystic abscess or resulting in generalized infected biliary peritonitis 
which carries high mortality reported as 30-50%. A localized perforation 
may involve the duodenum with the development of cholecystoduodenal 
fistula and resolution of the inflammatory episode. However this biliary 
enteric fistula persists and passage of large stone through  this fistula may 
eventually cause gall stone ileus. 
(5) Chronic cholecystitis 
             Chronic inflammation of the gall bladder is most commonly due to 
stones and the patients with chronic cholecystitis complain of recurrent 
attacks of epigastric or right  hypochondrial pain often radiating to right side  
of the back. The pain is more often persistent than intermittent. Nausea and 
vomiting may accompany episodes of persistent pain and the severe attacks 
of biliary colic. Jaundice may follow an attack and indicate common bile 
duct obstruction by a calculus. The only reliable sign which is frequently 
found on clinical examination is tenderness in the right upper quadrant. 
(6) Silent stones 
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Indication for surgery. 
Stone more than 2.5 cm, multiple stones, diabetic / immunosuppressed 
patients, if gallbladder wall thickened, high chances of developing 
gallbladder carcinoma 
(7) Mirizzi syndrome 
(8) Porcelain gallbladder 
(9) Hydrops gallbladder 
(10)Carcinoma gallbladder 
IN THE BILE DUCTS: 
(1) Obstructive jaundice 
(2) Cholangitis 
           Acute bacterial cholangitis is a serious life threatening emergency 
caused by infection of the obstructed biliary tract. In severe cases of 
cholangitis,  neutrophilic infiltration of the sinusoids and micro abscess 
formation in the hepatic lobules, portal  thrombosis and areas of hepatic 
necrosis are seen. The infection is commonly caused by gram negative 
organisms. The classical triad of symptoms consists of pain in right 
hypochondrium, intermittent fever and jaundice( charcot’s triad).complete 
triad is seen only in 70% of cases. The liver is often enlarged. Nausea, 
vomiting are frequent. 
(3) Acute pancreatitis 
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IN THE INTESTINE: 
(1) Biliary fistulous disease 
     The biliary enteric fistula due to gallstones are  cholecystoduodenal, 
cholecystogastric, choledochoduodenal, cholecystocholedochal and 
cholecystocolic. Of these cholecystoduodenal is the commonest. 
(2) Gall stone ileus 
 2% of patients with gallstones develop gallstone ileus. It is commonly 
present in elderly patients due to intraluminal intestinal obstruction by a 
large gall stone subsequent to a fistula either cholecystoduodenal or 
cholecystocolic. It presents commonly as small bowel obstruction and rarely 
as colonic obstruction. Most commonly, terminal ileum(70%) is the site of 
obstruction. Colonic obstruction is due to impaction in the colon as a result 
of cholecystocolic fistule. It is suspected when gas is present in biliary tree 
or gallstone is visualized in bowel lumen 
(3) Acute intestinal obstruction 
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INVESTIGATIONS: 
PLAIN ABDOMINAL X- RAY: 
              Only 10% gall stones are radio opaque and can be visualised. It will 
also show rare cases of calcification of gall bladder called as porcelain gall 
bladder. The importance of this appearance is an association with carcinoma 
in upto 25% patients. Rarely, the centre of a stone may contain radiolucent 
gas in a triradiate or biradiate fissure, and this gives rise to characteristic 
dark shapes on a radiograph – the ‘Mercedes-Benz’ or ‘seagull’ sign. Gas 
may be seen in the wall of the gall bladder(emphysematous gall bladder). 
BIOCHEMICAL INVESTIGATIONS: 
 Blood count – the count will be elevated in case of acute cholecystitis 
with polmorphonuclear leukocytosis.  
 Liver function test – bilirubin(conjugated) will be elevated in case of  
obstruction in the biliary tract. Serum alkaline phosphatase is markedly 
elevated and amino tranferase enzymes are elevated. Urine urobilinogen is 
absent, in case of obstructive jaundice. Alteration in liver function tests may 
be due to long standing obstruction of common bile duct due to gall stone or 
due to repeated attacks of ascending cholangitis and hepatitis. 
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ABDOMINAL ULTRASONOGRAPHY: 
 Ultrasonography is non invasive and is now the standard initial 
imaging technique for the investigation of the patient suspected of having a 
gall stone and is also the prime investigation for the patient presenting with 
jaundice. Sensitivity of ultrasonography to detect cholelithiasis is 95 to 99%. 
It will demonstrate biliary calculi, the size of gall bladder, the  thickness of 
the gall bladder wall, the presence of inflammation around the gall bladder, 
the size of the common bile duct and occasionally the presence of stones 
within the biliary tree. Endoscopic ultrasound using an endoscope which has 
a miniature ultrasound transducer mounted on its tip is valuable for detecting 
stones in or obstruction of the lower bile duct. It may prove unsatisfactory 
for technical reasons in the following obesity, previous surgery, ascites, 
gaseous distention of the upper abdominal viscera and distal part of common 
bile duct.  
ORAL CHOLECYSTOGRAPHY: 
 Visualisation of gall bladder by giving radio opaque dye. Contrast 
media is given which is excreted by the liver into the bile after its absorption 
in the intestine. Iopanoic acid is taken as tablets on the night before the 
examination. A control radiograph is taken before the tablets are given and a 
series of radiographs are taken on the following day, with further films after 
a fatty meal. The fatty meal stimulates gall bladder contraction and reveals 
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the adequacy of gall bladder function. This investigation has been discarded 
by most hospitals because of its inaccuracy except to show diverticulae and 
polyps and to assess function. Gall stones are seen as filling defects in the 
form of translucent areas in opaque shade of gall bladder. If the gall bladder 
does not contract to one third of its size in response to fatty meal, it indicates 
malfunction and is often associated with stones. 
INTRAVENOUS CHOLANGIOGRAPHY: 
               Biligrafin permits radiological visualisation of the bile ducts. 20 ml 
is injected very slowly into a vein. X rays are taken 10 to 40 mins after the 
injection. The biliary tract is frequently visualised due to higher 
concentration of the dye(about 50 to 100 times) with in the bile. For the gall 
bladder this investigation is inferior to oral cholecystography and it is not 
useful if bilirubin level is > 3mg%. 
OPERATIVE CHOLANGIOGRAPHY: 
 Types - intra operative and post operative.  
           Techniques – cystic duct cholangiography, 
cholecystocholangiography, CBD cholangiography, trans hepatic 
cholangiography, post exploratory cholangiography. 
 During open or laparascopic cholecystectomy a catheter can be placed 
in the cystic duct and contrast injected into the biliary tree. The technique 
defines the anatomy and is mainly used to exclude the presence of stones 
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within the bile ducts. A single x ray plate or image intensifier can be used  to 
obtain and review the images intra operatively. Irrespective of the technique 
used, the operating table should be tilted head down approximately 20 
degree to facilitate filling of the intra hepatic ducts. Care should be taken 
when injecting contrast not to introduce air bubbles into the system, as these 
may give the appearance of stone and leads to a false positive result.       
RADIO ISOTOPE SCANNING 
 Technetium 99m labelled derivates of iminodiacetic 
acid(HIDA,IODIDA)  when injected intravenously are selectively taken up 
by the retro endothelial cells of the liver and excreted into bile. This allows 
visualization of the biliary tree and gall bladder. The gall bladder is 
visualised within thirty minutes of isotope injection in 90% of normal 
individuals and within one hour in the remainder. The bowel is usually seen 
within one hour in the majority of patients.Non visualization of the gall 
bladder is suggestive of acute cholecystitis.If the patient has a contracted 
gall bladder as often occurs in chronic cholecystitis, gall bladder emptying 
may be reduced or delayed. Biliary scintigraphy may also be helpful in 
diagnosing bile leaks and iatrogenic biliary obstruction. When there is a 
suspicion of a bile leak following a cholecystectomy, radio isotope imaging 
should be performed. Scintigraphy can confirm the presence and quantify 
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the leak thus helping the surgeon to determine whether or not an operative or 
conservative approach is warranted. 
COMPUTERSIED TOMOGRAPHY 
                 This imaging modality allows visualisation of the liver, bile ducts, 
gall bladder and pancreas. It is particularly useful in detecting hepatic and 
pancreatic lesion and is the modality of choice in the staging of cancers of 
the liver, gall bladder, bile ducts and pancreas. In addition the presence of 
enlarged lymph nodes or metastatic disease can be seen. 
                  Gall stones are often not visualised and cholecystitis is 
underdiagnosed.However improvements in CT technology such as 
multidetector helical scanner that allow for three dimensional reconstruction 
of the biliary tree have led to greater diagnostic accuracy 
MAGNETIC RESONANCE CHOLANGIO 
PANCREATOGRAPHY(MRCP) 
 It is an imaging technique based on the principles of nuclear magnetic 
resonance used to image the gall bladder and the biliary system. It is non 
invasive and can provide either cross sectional or projection images. 
Contrast is not required and using appropriate techniques, excellent images 
can be obtained of the biliary tree that demonstrates ductal obstruction, 
strictures or other intra ductal abnormalities. The images obtained are 
comparable to those from endoscopic retrograde cholangiopancreatography 
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or percutaneous transhepatic cholangiography without the potential 
complication of either technique.It is applicable irrespective of altered or 
pathological anatomy that precludes endoscopic retrograde 
cholangiopancreatography. eg. Duodenal stenosis, hepatico jejunostomy. 
Thus the trend is to replace diagnostic ERCP with MRCP and restrict ERCP 
to those patients who require endoscopic intervention (endoscopic 
sphincterotomy and stone extraction , stenting) 
 
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY 
(ERCP) 
 In the prone position,using a side viewing endoscope the ampulla of 
vater can be identified and cannulated. Injection of water soluble contrast 
directly into the bile duct provides excellent images of the ductal anatomy 
and can identify causes of obstruction such as stones, malignant strictures. 
 Polythene cannula is made clear of air and flushed with 60% 
urograffin. The cannula is passed through the instrument taking care not to 
spill contrast medium into the duodenum since this stimulates peristalsis and 
makes cannulation difficult.Contrast medium is introduced slowly under 
fluoroscopic control. Both biliary and pancreatic ductal systems fill,but  
usually one duct fills first. If the pancreatic duct is filled first, contrast 
medium more than 2 to 2.5ml should not be injected. When the pancreatic 
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ductules at the tail are filled injection must be stopped, since overfilling will 
lead to extravasation and will cause pain. After pancreatography the tip of 
the cannula is readjusted to fill the biliary duct. Now 40ml of contrast can be 
used and preferably 25% hypaque is used to prevent obscuring of the small 
stones.  
MAIN INDICATIONS 
1. Jaundice—persistent and recurrent undiagnosed jaundice. 
2. biliary tract problems—undiagnosed upper abdominal pain and post 
operative biliary symptoms. 
3. Pancreatic diseases.       
It is used for diagnostic and therapeutic purposes. 
COMPLICATIONS FOLLOWING THERAPEUTIC 
INTERVENTIONS 
   1. Haemorrhage 
   2. Acute Pancreatitis 
   3. Cholangitis 
   4. Retroperitoneal duodenal perforation 
   5. Impacted dormia basket 
   6. Acute cholecystitis 
   7. Gall stone ileus—following extraction of large stones. 
PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY (PTC) 
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 This is an invasive technique in which the bile ducts are cannulated 
directly. It is only undertaken once a bleeding tendency has been excluded 
and the patient’s prothrombin time is normal. Antibiotics should be given 
prior to the procedure. Usualy under fluoroscopic control, a needle (chiba or 
okuda needle) is introduced percutaneously into the liver substance in the 8th 
inter costal space in mid axillary line. Under radiological control a bile duct 
is cannulated. Successful entry is confirmed by contrast injection or 
aspiration of bile. Water soluble contrast medium is injected to demonstrate 
the biliary system. Multiple images can be taken demonstrating areas of 
strictures or obstruction. It is used to provide external biliary drainage or the 
insertion of indwelling stents. The drainage catheter is placed in situ for a 
number of days and then dilating the track sufficiently for a fine flexible 
choledochoscope to be passed into the intra hepatic biliary tree inorder to 
diagnose strictures, take biopsies or remove stones. 
 If a malignant stricture at the level of the confluence of the right and 
left hepatic ducts or higher is suspected, a PTC is preferred to an ERCP. 
 
COMPLICATIONS 
1. Bleeding 
2. biliary leak and biliary peritonitis 
3. Septicemia 
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OPERATIVE BILIARY ENDOSCOPY (CHOLEDOCHOSCOPY) 
 At operation, a flexible fibreoptic endoscope can be passed down the 
cystic duct into the common bile duct enabling stone identification and 
removal under direct vision. The technique can be combined with an X ray 
image intensifier to ensure complete clearance of the biliary tree. After 
exploration of the bile duct, a tube can be left in the cystic duct remnant or in 
the common bile duct (a T tube) and drainage of the biliary tree established. 
After 7 to 10 days a track will be established. This track can be used for the 
passage of a choledochoscope to remove residual stone in awake patients. 
This technique is invaluable in the management of difficult stone disease and 
prevents the excessive prolongation of an operative exploration of the 
common bile duct. 
 
TREATMENT 
I. Non operative 
II. Operative 
(1) NON OPERATIVE TREATMENT 
ORAL DISSOLUTION THERAPY 
 Chenodeoxy cholic acid and Ursodeoxycholicacid are two naturally 
occurring bile acids used for oral dissolution of gallstones. 
CRITERIA FOR PATIENT SELECTION 
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        1. Solitary stones 
        2. Normal gall bladder function 
        3. Stone size less than 15 mm radiolucent 
        4. Cholesterol stones 
        5. Patients with mild and tolerable symptoms 
        6. Patient’s complaints should be reassured—treatment has a prolonged 
course 
 
CONTRAINDICATION OF DISSOLUTION THERAPY    
      1. Chronic liver disease 
      2. Severe and prolonged symptoms 
      3. Non-functioning gall bladder   
      4. Radio opaque stones 
      5. Stones greater than 3 cm or multiple 
      6. Concomitant hepato biliary diseases , inflammatory bowel disease or 
peptic ulceration 
MECHANISM OF ACTION 
 Chenodeoxycholic acid – specific inhibitor of HMG CoA reductase 
enzyme which is the rate limiting factor cholesterol bio synthesis. 
 Ursodeoxycholic acid –facilitates conversion of hepatic cholesterol to 
bile acids and also reduces the cholesterol absorption in intestine. 
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CHENODEOXYCHOLIC ACID 
 Naturally occurring primary bile acid(30 to 40% of bile acid pool) 
effective in reducing cholesterol saturation, alters the composition of bile by 
decreasing endogenous hepatic cholesterol synthesis and exogenous 
expansion of bile salt pool. Suppresses activity of HMG CoA reductase, a 
rate limiting enzyme for hepatic cholesterol synthesis. Dissolution takes 
place by molecule alteration of cholesterol from crystalline form to 
unsaturated mixed micelles. Dose 12 to 15 mg /kg/day as a single dose at 
bed time with a low cholesterol diet. 
URSODEOXYCHOLIC ACID 
           A seven beta hydroxyl epimer of chenodeoxycholate which is a 
primary bile salt of bears. Absorbed from the intestine, undergoes entero 
hepatic circulation, and gets conjugated with glycine and taurine with the 
liver. Apart from mechanism of action similar to CDCA it also causes 
increased bile output and decreases absorption of cholesterol from the gut. 
Dose 8 to 10 mg /kg /day or 600mg taken at bed time for 6 to 12 months. 
CONTACT DISSOLUTION THERAPY 
               A 5 French pigtail polyethylene catheter is inserted percutaneously 
into gall bladder under fluoroscopic control. Dissolution agent is repeatedly 
instilled and aspirated (10 ml is instilled and exchanged every 45 mins) 
agitating the gall bladder contents. Dissolution occurs within hours to days. 
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The procedure is terminated by removing the catheter and inserting a gel 
foam plug to prevent bile leakage. The solution should not be infused under 
pressure, should have a free access to the intestine and should not leak into 
peritoneal cavity.  
CHEMICALS USED 
                         1. Methyl ter-butyl ether :an aliphatic ether that effectively 
dissolves cholesterol stones. It is toxic to the CBD. It’s complications 
include hemolysis, duodenitis, mild anaesthesia, nausea and vomiting. An 
inflammable and toxic compound that can cause haemorrhagic 
peritonitis.Complication rate is 50 % 
                         2. Mono octanoic acid : A medium chain triglyceride  effective as a 
cholesterol solvent. A solution buffered to PH7.4 infused at 3 to 7 ml per 
hour would dissolve a stone in 5 days. success rate reported between 50 to 
80 %. When infused under pressure may cause respiratory distress or if it 
enters the duodenum results in diarrhoea, vomiting and abdominal cramps. 
Contact dissolution therapy in its present form is unlikely to have a clinical 
impact except in specialised centres with special equipment and requisite 
skill. Development of newer and safer solvents and in combination with 
other modalities like ESWL, trans catheter fragmentation using lasers , it 
may in the future find an application. 
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CHEMICAL CHOLECYSTECTOMY 
  This procedure is used with cholecystolithitomy which allows access 
to the gall bladder. It may become an important method of preventing stone 
recurrence because of the advent of non operative procedures as a treatment 
modality for gall stones. It has two components: Gall bladder ablation and 
cystic duct obstruction. A number of chemical sclerosants have shown to 
destroy gall bladder mucosa but reepithelialisation takes place from the 
cystic duct. Cystic duct occlusion using a bipolar electro coagulation 
catheter has overcome this. Thus chemical cholecystectomy in combination 
with stone removal in one stage offers a theoretical option for managing gall 
bladder stones and preventing recurrences. However this procedure is still in 
experimental stage and such an ablative iatrogenic procedure may possibly 
increase the likelihood of gall bladder cancer. 
 
EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) 
 It is produced by spark  gap (Dornier system),piezoceramic(Wolf 
system) or electromagnetic (Siemens system) generators which are focused 
by a concave reflector and targeted  under ultrasound guidance to the stones 
there by inducing fragmentations. The third generation machines avoid the 
need for immersion in a water bath and general anaesthesia. 
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INCLUSION CRITERIA 
1. Symptomatic gallstones 
2. Single radiolucent gallbladder stone with a diameter 3cm as determined 
by    ultrasound or upto 3 stones totalling a similar stone volume 
3. Functioning gallbladder on oral cholecystogram 
4. Calcification criteria.  Stones with a calcified rim 3cm or less in size, not 
stones   with diffuse calcification or multiple calcified stones or stones with 
a calcified nucleus. 
EXCLUSION CRITERIA 
1. Pregnancy 
          2. Symptomatic and proven peptic ulceration 
 3. Elderly with severe cardiac or respiratory complaints or with back 
problems  who  are unable to lie prone for 30 mins 
          4.  Radiological evidence of CBD stones 
          5. Jaundice/ hepatitis/ cirrhosis 
          6. Acute cholecystitis 
          7. Acute pancreatitis 
          8. coagulopathy 
          9. Vascular aneurysm 
MORBIDITY FOLLOWING ESWL: 
1. Hematuria – 3% 
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2. Petichiae at cutaneous entry site – 4% 
3. Biliary pain by passage of fragments through biliary tree – 35% 
4. Transient cystic duct obstruction – 5% 
5. Pancreatitis – 1% 
               Under the current criteria only 0 – 20% of all symptomatic 
and uncomplicated gall bladder stones can be treated with ESWL. The 
technology of ESWL for a gall stone will improve with time, 
increasing the efficacy of stone fragmentation while maintaining a 
low level of discomfort for the patient. Long term follow up studies 
are needed to define the place of ESWL in management of gall stone. 
 
(2)SURGICAL TREATMENT: 
1. OPEN CHOLECYSTECTOMY 
2. LAPARASCOPIC CHOLECYSTECTOMY  
3. CHOLECYSTOSTOMY 
OPEN CHOLECYSTECTOMY: 
Indications: 
• Calculous cholecystitis with or without symptoms  
• Acute or chronic acalculus cholecystitis 
• Torsion of gall bladder  
• Trauma to the gall bladder 
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• Carcinoma gall bladder  
• Biliary peritonitis with or without demonstrable perforation 
• Following cholecystostomy 
a. As a second stage procedure 
b. Where there is persistent biliary or mucous discharge 
c. In patients with recurrent gall stones treated by non operative modality 
Position of the patient: Patient should lie in supine position with 
operating table slightly tilted up on the right. 
Incisions: Upper midline, right paramedian or right subcostal 
(Kocher’s) incisions are used. 
Adhesions b e t w e e n  g a l l b l a d d e r   and  adjacent  viscera  
are  freed.  If  the gallbladder  is  tense  it  is  aspirated. The  most  
important  step  is  to  pack  the operative field with three gauze 
packs. 
i) Placed over the hepatic flexure of colon. 
ii) Placed over the 1st part of duodenum and stomach.  
 iii)   Placed  over  the  under  surface  of  the  right  lobe  of  liver  
medial  to gallbladder and held in place by means of retractor. 
Open Cholecystectomy done by two methods: 
1)  Fundus first method 
2)  Duct first method (retrograde) 
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Fundus first method:  
1. Gallbladder  fundus  held  with  sponge holding  forceps  all  
adhesions  are  cleared  from  gallbladder  bed.  Cystic artery is 
isolated, separated and ligated close to the gallbladder, cystic duct 
is dissected and traced to its junction with CHD and ligated and 
divided. 
2. Gallbladder with its contents are removed. 
Duct first method: 
 Fundus  of  the  gallbladder  held  with  sponge  holding  forceps  
and  drawn downwards and outwards.Hartman’s pouch is held with 
another tissue forceps and is drawn downwards and to the right so that 
the calots triangle with cystic artery is exposed.Cystic artery is ligated 
close to the gall bladder wall and divided.By ligating cystic artery, 
subsequent dissection can be carried out without any danger of  
haemorrhage. The junction of cystic duct,  CHD and bile duct is 
recognized and clearly dissected out.  Cholangiography is carried out 
and then cystic  duct  is  ligated  and  divided.  Peritoneum  is  incised  
at  the  gallbladder margin  and  cleavage  plane  between  liver  and  
gallbladder  made using  blunt dissection. Vessels in the gallbladder bed 
are controlled by diathermy coagulation.  Drainage  tube  is  put  in  
the  region  of  divided  cystic  duct  and brought outside through 
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separate stab incision 
ADVANTAGES OF OPEN CHOLECYSTECTOMY: 
a. Eradication of more specific symptoms of gall stones 
b. Prevents complications of gall stones 
c. No recurrence of gall stones 
d. Procedure allows full inspection of abdominal viscera 
DISADVANTAGE OF OPEN CHOLECYSTECTOMY: 
a. Requires hospitalisation for 7 – 10 days 
b. Inflicts considerable discomfort to the patient 
c. About 47%of patients continue to complain of some persistence of 
symptoms. 
Post cholecystectomy syndrome is due to 
a. Retained stones in the bile duct 
b. Long cystic stump remnant 
c. Ampullary stenosis 
d. Sphincter of oddi dysfunction 
COMPLICATION: 
¾ Haemorrhage 
¾ Biliary injury and stricture 
¾ Biliary fistula 
¾ Post operative jaundice  
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¾ Accumulation of bile in right sub phrenic or sub hepatic region leads to 
waltman walter’s syndrome 
¾ Infection 
MINI CHOLECYSTECTOMY: 
         A standard mini cholecystectomy is performed through a 5 cm midline 
incision using special instruments and the modern fixed retractor system for 
exposure. This limited exposure prevents a full abdominal exploration and 
hence leads to less post operative discomfort, paralytic ileus and quicker 
recovery thereby reducing the hospital stay which are the chief drawbacks of 
the standard cholecystectomy. 
 A more recent modification has been described as “CYLINDRICAL 
CHOLECYSTECTOMY”. 
 The operation is based on the introduction of a 3.8 – 5.0cm diameter 
cylinder that is 10cm long which isolates the hepatocystic region from the 
surrounding structures and thus facilitates the intervention. 
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PARTIAL CHOLECYSTECTOMY(SUBTOTAL 
CHOLECYSTECTOMY): 
             In case of severe adhesion and difficulty in identifying calot’s 
triangle, gall bladder fundus is opened first and the stones and contents were 
removed. Then subtotal resection of the gall bladder is done leaving the 
posterior wall attached to the hepatic bed. 
           A modification using a 1 cm rim of hartmann’s pouch to buttress and 
occlude the intestinal opening of the cystic duct and leaving the structures of 
calots triangle undisturbed. 
LAPAROSCOPIC CHOLECYSTECTOMY: 
          In  1987,  first  cholecystectomy  was  done  in  France and in  
1989 in the US.  This technique is gaining popularity in India. It is 
based on the good cosmetic result,  rapid resolution of  post operative pain, 
and a reduction of hospitalization with the ability to return to work soon 
after surgery.  
Indications   :  
1. Cholelithiasis 
2. Symptomatic gall bladder polyps 
3. Resolving gall stone pancreatitis 
4. Symptomatic chronic cholecystitis 
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Contraindication: 
              Relative: 
1. Acute cholecystitis  
2. Prior upper abdominal surgery 
3. Common bile duct stones 
4. COPD with acidosis and hypercarbia 
5. Mirizzi’s syndrome 
               Absolute: 
1. Acute cholangitis  
2. Severe acute cholecystitis 
3. Acute pancreatitis  
4. Peritonitis 
5. Portal hypertension 
6. Pregnancy 
7. Serious bleeding diathesis 
 Complications: 
1. Bleeding- slipped clip 
2. Bile leak 
3. Bowel injury 
4. Biliary injury 
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Procedure :  The procedure is performed under general anaesthesia 
or epidural anaesthesia. Urinary  bladder  is  emptied. Stomach  is  
decompressed  using, nasogastric tube. 
Initiation of pneumoperitoneum and placement of canulas. 
½  inch  incision  is  made  just  above  the  umbilicus  and  verres  
needle introduced  into  the abdominal cavity through trocar and 
canula . The needle is connected  to  the  CO2    insufflator  and  
peritoneum  is  instilled  with CO2    upto 12 mmHg pressure is  
reached. Rate of flow of CO2   is 6- 10 litre/min. Laparoscope is 
inserted and  abdominal  cavity is inspected. Second canula inserted in 
the upper abdomen  2/3rd  of  way  between  the  umbilicus  and  
xiphisternum. One  5.5  mm cannula is inserted 3- 4 cms below right 
costal margin (RCM) in the mid clavicular line (MCL). Second 5.5 
canula is inserted 4- 6 cm below right costal margin in mid axillary 
line.Umbilical canula is used to introduce endoscope (11mm). The two 
5.5 mm ports are  used to retract and expose the gallbladder. The 
operative procedure is similar to antegrade 
cholecystectomy(fundusfirst) 
 
 
 
72 
 
CHOLECYSTOSTOMY: 
         This option of simple drainage of gall bladder combined with removal 
of any stones is occasionally indicated 
a. If it deemed that a cholecystectomy would be technically difficult- 
Severe inflammatory changes rendering the anatomy obscure. 
b. In poor risk patients 
c. For a preliminary drainage of the biliary tree obstructed by tumour in 
whom later resection is contemplated.  
        Usually performed via a sub costal incision under a local or regional 
anaesthesia. A  T  tube cholangiogram and definitive surgery is performed 
after an interval of 6 to 12 weeks. 
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Plain x-ray of abdomen showing gallstones 
 
Ultrasound abdomen showing gallstones in gallbladder 
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Oral cholecystogram showing gallstones in the gallbladder 
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Cholecystogram 
Ultrasound showing Gallstones in the gallbladder 
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Mini Laparoscopic Cholecystectomy 
 
Laparoscopic cholecystectomy 
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COLLECTION OF BILE FOR CULTURE 
 
OPEN CHOLECYSTECTOMY 
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LAPARASCOPIC CHOLECYSTECTOMY 
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LAPRASCOPIC CHOLECYSTECTOMY 
 
 
LAPARASCOPY CONVERTED TO OPEN CHOLECYSTECTOMY 
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PETRI DISH WITH CULTURE MEDIA 
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ANTIBIOTIC SESTIVITY TEST 
METHODOLOY 
Source of data : 
Patients  admitted  to  T i r u n e l v e l i   M e d i c a l  C o l l e g e  
H o s p i t a l   with  the  diagnosis  of Gallstone disease   were taken for 
this observational study from March 2011  to October 2012. 
Type of study: 
            It is a prospective study. 
Inclusion criteria : 
 Patients of  age >12 years and <65 years 
All proven  cases of gallstone disease who got admitted to the hospital 
for cholecystectomy  both  open and laparoscopic cholecystectomy. 
Exclusion criteria : 
Acute chole cystitis 
Acute acalculus cholecystitis Emphyema gall bladder Mucocele of the 
gall bladder 
Jaundice patients  
Gallstones  with  multiple  common  bile  duct  stones  (multiple  CBD  
and intrahepatic stones). 
Patients who refused surgery 
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TOTAL NUMBER OF PATIENTS : 50 
Proforma: Details of proforma and master chart attached in the 
annexure 
Sample collection : 
a) Bile : 
 Bile was aspirated from the gallbladder of the patient who 
underwent open cholecystectomy using a sterile syringe (5ml) .In case 
of laparoscopic cholecystectomy, bile was collected from excised  gall 
bladder. The  sample was collected in sterile bottle and was transferred 
to microbiology laboratory. In  the laboratory the bile sample was 
inoculated in the basal media like nutrient agar, MacConkey agar, blood 
agar in the temperature of 37oc   and  the  results  were read  after  18-24  
hours  for growth of organisms. Identification of species was done using 
biochemical tests like indole test, citrate test, urease test, TSI test, 
oxidase test, gram staining, motility test. Antibiotic sensitivity testing 
was done after identification of the organism.  Antibiotic sensitivity test 
was done with amikacin, gentamycin, ciprofloxacin, ceftazidime, 
cefotaxime, ceftriaxone, cotrimoxazole, ceftazidime + clavulanic acid 
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AGE AND SEX DISTRIBUTION 
 In our study the age group of 51 – 65 years was more commonly 
affected, 22 among 50 cases were found to belong to this group. Females 
were more commonly affected in the ratio of 3:2. 
 
 
AGE MALE FEMALE TOTAL 
13-20 0 0 0 
21-30 2 5 7 
31-40 4 8 12 
41-50 1 8 9 
51-65 12 10 22 
TOTAL 19 31 50 
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CLINICAL PRESENTATIONS OF GALL STONE 
 The most common clinical presentation among the cases studied was 
abdominal pain, all the cases studied presented with abdominal pain. The 
second most common presentation was nausea/vomiting, which was the 
presenting symptom in 18 cases. 
 
PRESENTATION CASES 
ABDOMINAL PAIN 50 
FEVER 11 
NAUSEA/VOMITING 18 
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BACTERIOLOGY OF BILE CULTURE IN GALL STONE DISEASE 
 Culture reports  of the bile revealed organism  in 21 cases.  
KLEBSIELLA was the most common organism followed by E-Coli.  
BACTERIA NO.OF CASES 
Klebsiella 10 
E.coli 4 
Coagulase(-) staphylococcus aureus 3 
Proteus vulgaris 2 
Pseudomonas 2 
No growth 29 
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COLOUR OF GALL STONES 
 In our study most of the stones recovered from the gall bladder were 
Black/Pigment stones, which constituted 68% of the cases studied. 
COLOUR NO.OF CASES 
BLACK/PIGMENT STONES 34 
YELLOW/CHOLESTEROL 
STONES 
16 
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SURGICAL TREATMENT 
Total number of cases operated -50  
 
PROCEDURE NO.OF CASES 
OPEN CHOLECYSTECTOMY 28 
LAPAROSCOPIC 
CHOLECYSTECTOMY 
17 
LAPAROSCOPY CONVERTED TO 
OPEN 
5 
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DISCUSSION 
            The age and sex incidence of gallstone formation observed in 
our study is given in Table no 1 and Fig 1 of results. The incidence was 
more in females (62%) 31 numbers than in males (28%)- 19 numbers 
among the total 50 cases. Similar observations were given by National 
Academy of Medical Sciences in Nepal. However in the study of C-Y 
Chen et al 1995 the incidence is more common in males. The incidence 
of gallstone was highest (22 numbers) in 51 to 65 year age group in both 
males and females followed  by age group 31-40 years (12nos). 
  The sex distribution of gallstone formation observed in our study 
was found to be comparable and similar to the observation made by 
Ahmed H Kissebah et al.  
 The clinical presentation of gallstone disease observed in our 
study was abdominal pain followed by nausea and vomiting. The 
observations of our study  were similar to that of  Multicentre Italian 
Study of Cholelithiasis, DIEHL et al and Kelinische waarde van et al 
Netharlands. 
The bacteriology of bile culture observed in our study  [ Table no 
3 Fig no 3 of results] revealed KLEBSIELLA as the  commonest 
organism    followed by Escherichia Coli. However in the study of 
Chang WTLee et al1991-2000, Muhsin Kaya et al Turkey 2010-2011 
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and Manojkumar Sahu, Amith Kumar Datta et al 2007-2008 the 
commonest organism was E.Coli. 
The colour of Gallstones observed in our study  [ Table no 4 and 
Fig.4].  was black pigment stone(34nos) similar to the obsrevations  
made by Pammysinha et al.  
 In our series out of 50 cases, 28 cases were treated with open 
cholecystectomy, 17 patients with laproscopic cholecystectomy and in 5 
petients laproscopic cholecystectomy was converted to open 
cholecystectomy. 
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CONCLUSION 
From observation of our prospective study of  50  cases , the 
following conclusions were derived 
¾ Gallstone  disease  is  common  in  females than in the males and    the  
age  group  was  51 to 65 years. 
¾ All the cases  presented with right  hypochondriac  pain . Nausea and 
vomiting were present  in 18 cases  and fever was present in 11 
cases. 
¾ Ultrasound abdomen was the main investigation to detect gall stones 
and MRCP to know the anatomy of  common bi le  duct . 
¾ In our study, 28 patients underwent open cholecystectomy , 17 
patients underwent laparoscopic cholecystectomy and 5 patients 
underwent laparoscopy which was converted to open 
cholecystectomy for practical difficulties. 
¾  21 cases showed organisms in  bile culture  –of which   17  were  
females  and 4 were  males . 
¾ The  most common  microorganism  isolated  from  bile  culture  
was  Klebsiella in our study  although  E. Coli is the commonest 
organism as per standard text books.Our study revealed E.Coli 
growth only in 4 patients. 
¾ 34 cases in our study showed pigment stones and 16 cases were 
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cholesterol stones. 
¾ Histopathological  examination  of  gallbladder wall  showed 
features of  chronic  calculus  cholecystitis in all the cases. 
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ANNEXURE 
ANNEXURE – I PROFORMA 
 
NAME  :  
AGE  :  I.P. No.   :   SEX : WARD No : 
RELIGION : UNIT     :  OCCUPATION :  
D.O.A.    :    ADDRESS :  
D.O.S.  :   D.O.D. : 
COMPLAINTS 
1. Abdominal Pain   : 
2. Sensation of Fullness  : 
3. Nausea and Vomiting  : 
4. Jaundice    : 
5. Fever     : 
6. Mass     : 
7. Itching over the body  : 
8. Appetite    : 
9. Bowel habits   : 
10.  Colour of the urine  : 
 
 
  
HISTORY OF PRESENTING ILLNESS 
1.  Abdominal Pain  
 a.    Mode of onset  
 b.    Site of pain 
 c.    Character of pain 
 d.    Duration of each attack 
 e.    Radiation or referred pain 
 f.  Effect of pressure and respiration 
 g.  Relation to food 
 h.  Relieving factors / Aggravating factors 
2.   Sensation of Fullness 
3.   Nausea and vomiting 
4.   Jaundice 
 a. Duration  
 b.   Sites 
 c.    Intensity  
 d.    Type 
 e.    Itching 
 f. Variation in intensity  
 g.    Recurrent attacks 
 
  
5.   Fever 
 a.   Duration  
 b.    Type 
 c.   Severity 
 d.   Diurnal variation 
 e.   Associated with chills and Rigors 
6.   Mass / Lump 
 a.   Site 
 b.  Mode of onset  
 c.   Progression 
 d.  Pain in the swelling 
 e.  Any associated factors  
 f.  Blood disorders 
PAST HISTORY 
1.   Jaundice with pain and fever 
2.   Similar attacks of pain 
3.   Blood transfusion 
4.   Vaccination 
5.   Drugs 
6.   Abdominal surgery like 
7.   Enteric fever 
  
PERSONAL HISTORY 
1.   Diet 
2.   Appetite 
3.   Dislike for fatty food 
4.   Sleep 
5.   Alcohol amount and quantity 
6.   Smoking 
7.   Bowel habits 
 a.  Amount of stool  
 b.   Colour of stool 
8.   Micturation  : 
 a.  Amount of urine  
 b.  Colour of urine 
MENSTRUAL HISTORY 
1.  Menarche 
2.   LMP 
3.   PARA 
4.   Post Partum 
5.   Abortion 
FAMILY HISTORY 
1. Jaundice 
  
2. Gallstones 
3. Diabetes  
TREATMENT HISTORY HISTORY OF ALLERGY 
PHYSICAL EXAMINATION 
1. General appearance : 
2. Built 
3. Anemia 
4.   Cyanosis ± 
5.   Clubbing ± 
6.   Lymphadenopathy 
7.   Jaundice 
8.   Anasarca 
9.   Thrombophlebitis 
10.  Spider naevi 
VITAL SIGNS 
1. Pulse 
2.   Blood pressure 
3.   Respiratory rate 
4.   Temperature 
ABDOMINAL EXAMINATION Inspection 
.   Contour 
  
. Movement of all quadrants with respiration 
. Skin 
. Engorged veins 
. Visible pulsations and peristalsis 
. Umbilicus 
. Hernial orifices 
. External genitalia 
Swelling 
. Site - Surface 
. Size - Borders 
. Shape - Movement with 
. Extent - Plane of the swelling 
Palpation 
1.  Local rise of temp/hyperaesthesia  7.    Surface 
2.  Tenderness      8.   Borders 
3.  Position       9.  Mobility 
4.  Size       10. Murphy's sign ± 
5.  Shape       11. Consistency 
6.  Extent       12. Plane of the swelling 
13. Liver 
 Size 
 Borders 
  
 Consistency 
 Surface 
 Mobility with respiration 
14. Spleen 
PERCUSSION 
 Light percussion of abdomen 
AUSCULTATION Systemic examination 
 Cardiovascular System 
 Respiratory system 
 Central nervous system 
PROVISIONAL DIAGNOSIS INVESTIGATIONS 
1.  Blood  
 a.   HB 
 b.   TC DC 
 c.   CT  
 d.   PTT  
 e.   BT  
 f.   PT 
 g.  RBS 
 h.  Blood Urea 
 i.   Serum Cholesterol  
  
 j.   Serum Creatinine 
2.  Urine 
 a.   Albumin    c. Microscopy  
 b.   Sugar     d.  Colour 
3.  Liver Function tests: 
 a.   S. Bilirubin 
 b.  S. Alkaline Phsophate  
 c.  S. Albumin 
 d.  S. Globulin  
 e.   SGOT 
 f. SGPT 
 g.  Total proteins 
4.  Ultrasound 
5.  Radiological examination 
6.  CT Scan 
DIAGNOSIS TREATMENT 
Medical 
Surgical - Open 
                     Laparoscopic 
Postoperative investigations : 
Bile culture report  Histopathological report 
  
                                                                                      MASTER CHART 
S.NO NAME AGE SEX IP NO 
CLINICAL 
FEATURES SURGER
Y 
USG 
ABDOME
N 
TYPE    
OF 
STONE 
BILE 
CULTUR
E A.P OTHERS 
1 Parameswari 24 F 10193 + - L + C Pseudo 
2 Ragumath nisha 35 F 10336 + - L + P Kleb 
3 Seeniammal 50 F 10366 + N/V O + P Kleb 
4 Arputhamani 55 F 10148 + N/V L + P NG 
5 Thirumalmani 40 M 18579 + - L=>O + P NG 
6 Michel 54 M 19679 + F/N/V O + C NG 
7 Esakkiappan 30 M 24116 + - L=>O + P Kleb 
8 Thangammal 55 F 23408 + F/N/V O + C NG 
9 Vasantha 32 F 24176 + - L + C Staph 
10 Palanichamy 58 M 24850 + - O + P NG 
11 Alagu sundaram 57 M 30734 + - O + P NG 
12 Balasubramanian 57 M 35420 + - L=>O + C NG 
13 Narayannan 64 M 40063 + F/N/V O + P NG 
14 Vallithai 40 F 40730 + - L + P NG 
15 Chandra 40 F 42123 + - O + C NG 
16 Arumugthammal 47 F 40035 + - O + P NG 
  
17 Elango 34 M 43394 + - L + P NG 
18 Guruvammal 60 F 45080 + F/N/V O + P Kleb 
19 Murugan 60 M 46869 + - O + P NG 
20 Jeyalakshmi 51 F 46904 + - L + C NG 
21 Santhosam 64 F 49471 + F/N/V O + P NG 
22 Thirumalai 55 M 47689 + - O + P Kleb 
23 Mohammed 54 M 52562 + - O + P NG 
24 Paulsamy 40 M 52217 + - O + P NG 
25 Sudalaimadathy 50 F 39612 + - O + P NG 
26 Banu 35 F 47948 + N/V L + P NG 
27 Soosaimuthu 50 M 47116 + F/N/V O + C Staph 
28 Sudalaiammal 63 F 55270 + - O + P E.coli 
29 Sarojini 60 F 51978 + - L + P Kleb 
30 Neelavathy 62 F 58586 + - O + P NG 
31 Sudalai 65 F 57346 + F/N/V O + C NG 
32 Mallika 26 F 7720 + N/V L + P NG 
33 Palkani 30 F 12821 + - L + C Kleb 
34 Rakkumuthu 65 M 7678 + F/N/V O + P Kleb 
35 Narayanan 60 M 9954 + - O + P NG 
36 Prem kumar 23 M 12704 + - L + C NG 
37 Lakunan 52 M 29019 + - O + C NG 
  
38 Shanthi 42 F 24163 + - O + P Proteus 
39 Sundari 52 F 25134 + - L=>O + P Kleb 
40 Rajeswari 32 F 7624 + - L=>O + P Kleb 
41 Gomathy 49 F 55266 + - O + P E.coli 
42 Mariammal 44 F 52245 + N/V O + C NG 
43 Vijaya 33 F 56536 + - L + C Staph 
44 Rajathi 56 F 2794 + F/N/V O + P Proteus 
45 Latha 29 F 6452 + N/V L + P E.coli 
46 Ramalakshmi 37 F 49218 + F/N/V L + P NG 
47 Arumugakani 26 F 50201 + N/V L + P E.coli 
48 Kaladevi 50 F 48486 + - O + C Pseudo 
49 Thangaiah 59 M 53023 + F/N/V O + C NG 
50 Pattan 40 M 52267 + - L + P NG 
 
A.P- Abdominal Pain                                     NG – No Growth 
F – Fever                             L – Laparoscopic cholecystectomy 
N – Nausea                                        O – open cholecystectomy 
V – Vomiting                              Staph – staphylococcus aureus 
C – Cholesterol stone                                       Kleb - Klebsiella 
P – Pigment stone                                   Pseudo - Pseudomonas 
